Literature DB >> 3352902

Seronegative myasthenia gravis.

B C Soliven1, D J Lange, A S Penn, D Younger, A Jaretzki, R E Lovelace, L P Rowland.   

Abstract

Of 221 patients with myasthenia gravis, 18.5% had no detectable antibodies to acetylcholine receptor. Seven of 14 patients (50%) with only ocular symptoms for more than 2 years were seronegative, and 25 of 145 (17%) patients with generalized myasthenia were seronegative. The clinical characteristics of seronegative patients did not differ from patients with high antibody titers. No seronegative patient had a thymoma, but that difference did not reach statistical significance. Lack of serum antibodies did not preclude favorable response to thymectomy or plasmapheresis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3352902     DOI: 10.1212/wnl.38.4.514

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis.

Authors:  Y Nemoto; S Kuwabara; S Misawa; N Kawaguchi; T Hattori; M Takamori; A Vincent
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-05       Impact factor: 10.154

2.  Ocular myasthenia gravis: response to long-term immunosuppressive treatment.

Authors:  N Sommer; B Sigg; A Melms; M Weller; K Schepelmann; V Herzau; J Dichgans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

3.  Repertoires of autoantibodies against homologous eye muscle in ocular and generalized myasthenia gravis differ.

Authors:  C W Zimmermann; F Eblen
Journal:  Clin Investig       Date:  1993-06

4.  Oculo-bulbar myasthenic symptoms as the sole sign of tumour involving or compressing the brain stem.

Authors:  A Straube; T N Witt
Journal:  J Neurol       Date:  1990-10       Impact factor: 4.849

Review 5.  Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects.

Authors:  N Sommer; A Melms; M Weller; J Dichgans
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

Review 6.  Ocular myasthenia gravis.

Authors:  G A March; L N Johnson
Journal:  J Natl Med Assoc       Date:  1993-09       Impact factor: 1.798

7.  Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis.

Authors:  Pedro M Rodríguez Cruz; Michal Al-Hajjar; Saif Huda; Leslie Jacobson; Mark Woodhall; Sandeep Jayawant; Camilla Buckley; David Hilton-Jones; David Beeson; Angela Vincent; Maria Isabel Leite; Jacqueline Palace
Journal:  JAMA Neurol       Date:  2015-06       Impact factor: 18.302

8.  Factors predicting surgical outcome of thymectomy in myasthenia gravis: A 16-year experience.

Authors:  Nilkamal Kumar; A K Verma; A Mishra; G Agrawal; A Agrawal; U K Misra; S K Mishra
Journal:  Ann Indian Acad Neurol       Date:  2011-10       Impact factor: 1.383

9.  Myasthenia gravis and acetylcholine receptor antibodies: a clinico immunological correlative study on South Indian patients.

Authors:  P S Bindu; M Nirmala; S A Patil; A B Taly
Journal:  Ann Indian Acad Neurol       Date:  2008-10       Impact factor: 1.383

10.  Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status.

Authors:  Shin Joong Oh
Journal:  J Clin Neurol       Date:  2009-06-30       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.